Ribociclib in combination with a nonsteroidal aromatase inhibitor (NSAI) improved invasive disease-free survival (iDFS) while allowing for better quality of life in hormone receptor-positive (HR+)/human epidermal growth receptor 2-negative (HER2−) early breast cancer.
Pharmacists’ accessibility and expertise in medication management make them ideal health care providers to discuss prevention strategies, medication adherence, and potential adverse effects.
Student loan repayment is evolving — new doctors need to make smart, strategic choices on forgiveness, IDR plans and refinancing this year.
Base editors can correct disease-causing genetic variants. After a neonate had received a diagnosis of severe carbamoyl-phosphate synthetase 1 deficiency, a disease with an estimated…
Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA, co-chair of the 2025 Oncology Pharmacists Connect (OPC) meeting, discusses what makes the event unique, highlights key sessions, and…
Mayo Clinic physician Dr. Rosenthal shares three topics that younger people with cancer often want to discuss with their healthcare teams.
The high prevalence of occupational distress in health care workers and its implications for quality of care are now widely recognized by health care organizations.…
Digital health companions — powered by telehealth and informed by multiple data sources and artificial intelligence — offer the possibility of affordable, “always on” care…
Study uses an evolutionary modeling approach known as a “fitness seascape” to simulate how bacterial resistance develops in response to real-world treatment patterns.
In the age of telemedicine, house calls remain a vital part of primary care—and are in fact on the rise. Indira Subramanian reports House calls…
Building on positive event-free survival (EFS) and overall survival (OS) rates in the original analysis of CheckMate 77T, new results indicate sustained survival over 3…
